Nalls Sherbakoff Group’s iShares US Medical Devices ETF IHI Stock Holding History

Nalls Sherbakoff Group’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$45.4K	Hold	918	–	–	0.03%	193
2026 Q1	$49K	Hold	918	–	–	0.04%	193
2025 Q4	$57.1K	Hold	918	–	–	0.04%	187
2025 Q3	$55.2K	Hold	918	–	–	0.04%	200
2025 Q2	$57.5K	Hold	918	–	–	0.04%	189
2025 Q1	$55.3K	Buy	+918	New	+$57K	0.04%	174
2023 Q4	$49.6K	Hold	918	–	–	0.04%	164
2023 Q3	$44.5K	Hold	918	–	–	0.04%	160
2023 Q2	$48.6K	Hold	918	–	–	0.05%	159
2023 Q1	$48.8K	Buy	+918	New	+$48.9K	0.05%	163
2018 Q4	$30K	Buy	+900	New	+$31.2K	0.05%	186

Other funds holding IHI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Nalls Sherbakoff Group's IHI Position: Q2 2026 in Review

Nalls Sherbakoff Group held its iShares US Medical Devices ETF (IHI) position steady in Q2 2026 at 918 shares worth $45.4K. The position accounts for 0.03% of the portfolio, ranked #193.

Nalls Sherbakoff Group first reported a position in IHI in Q4 2018 and has held it in 11 quarters since. The position peaked at $57.5K in Q2 2025. 501 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

Nalls Sherbakoff Group held 918 shares of iShares US Medical Devices ETF worth $45.4K as of Q2 2026.
Nalls Sherbakoff Group left its iShares US Medical Devices ETF share count unchanged in Q2 2026.
iShares US Medical Devices ETF made up 0.03% of Nalls Sherbakoff Group's portfolio in Q2 2026, its #193 holding.
Nalls Sherbakoff Group first reported a position in iShares US Medical Devices ETF in Q4 2018 and has held it in 11 quarters since.
Nalls Sherbakoff Group's iShares US Medical Devices ETF position peaked at $57.5K in Q2 2025.
501 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Nalls Sherbakoff Group's 13F filing for Q2 2026, filed 17 Aug 2026.